Research Library — Page 52 | Reta Compare
3563 research articles. Page 52 of 143.
Articles
- Retatrutide Shows Promise in Alleviating Steatohepatitis in Mouse Model
- Exploring Retatrutide's Role in Glucagon Signaling for Metabolic Disorders
- Exploring Appetite Changes with Retatrutide in Type 2 Diabetes Management
- Retatrutide's Impact on Cardiac Function in Mouse Atrial Preparations
- Exploring Retatrutide's Role in Diabetes and Chronic Kidney Disease Management
- Understanding Gastrointestinal Adverse Effects of Retatrutide in Non-Diabetic Adults
- Exploring Retatrutide: Insights from Recent FDA-Approved Obesity Therapies
- Exploring the Role of Retatrutide in Obesity Management and Weight Loss
- Retatrutide's Efficacy and Safety Compared to GLP-1 and Dual Agonists for Weight Loss
- Exploring the Role of Retatrutide in Weight Loss Among Obese Individuals Without Diabetes
- Evaluating the Efficacy of Retatrutide in Chronic Kidney Disease: Insights from TRANSCEND-CKD
- Exploring Retatrutide: Insights from Triple GLP-1R/GCGR/GIPR Agonist Research
- Exploring Retatrutide's Role in Treating Metabolic Dysfunction-Associated Liver Disease
- Exploring the Impact of Eating Behaviors on Weight Change with Retatrutide
- Retatrutide Treatment Reduces ANGPTL3/8 Levels and Serum Lipids
- Retatrutide's Role in Treating Metabolic Dysfunction-Associated Liver Disease
- Retatrutide and Muscle Preservation: Strategies for Effective Weight Loss
- Retatrutide and Its Role in Blood Pressure Management: Insights from Recent Research
- Exploring the Role of Retatrutide in Treating Polycystic Ovarian Syndrome
- Evaluating Pancreatitis and Cancer Risks Associated with Retatrutide and GLP-1 Receptor Agonists
- Exploring Retatrutide: A Promising Dual Agonist in Obesity Treatment
- Retatrutide's Role in Dual and Triple Incretin Agonist Therapies for Type 2 Diabetes
- Exploring Retatrutide: Advances in Incretin Co-Agonists for Cardiometabolic Health
- Retatrutide's Impact on Body Composition in Type 2 Diabetes Patients
- Exploring the Role of Retatrutide in Modern Obesity Management